Mallinckrodt PLC (Mallinckrodt) is an Ireland-incorporated specialty pharmaceutical company. As a credit analyst, you have been asked

Question:

Mallinckrodt PLC (Mallinckrodt) is an Ireland-incorporated specialty pharmaceutical company. As a credit analyst, you have been asked to assess its creditworthiness—on its own, compared to a competitor in its overall industry, and compared with a similarly rated company in a different industry. Using the financial statements provided in Exhibits 10 through 12 for the three years ending 31 December 2015, 2016, and 2017, address the following:

1. Calculate Mallinckrodt’s operating profit margin, EBITDA, and free cash flow after dividends. Comment on what these measures indicate about Mallinckrodt’s profitability and cash flow.

2. Determine Mallinckrodt’s leverage ratios: debt/EBITDA, debt/capital, free cash flow after dividends/debt. Comment on what these leverage ratios indicate about Mallinckrodt’s creditworthiness.

3. Calculate Mallinckrodt’s interest coverage using both EBIT and EBITDA. Comment on what these coverage ratios indicate about Mallinckrodt’s creditworthiness.

4. Using the credit ratios provided in Exhibit 11 on Johnson & Johnson, compare the creditworthiness of Mallinckrodt relative to Johnson & Johnson.

5. Compare the Exhibit 12 credit ratios of Luxembourg-based ArcelorMittal, one of the world’s largest global steelmakers, with those of Mallinckrodt. Comment on the volatility of the credit ratios of the two companies. Which company looks to be more cyclical? What industry factors might explain some of the differences? In comparing the creditworthiness of these two companies, what other factors might be considered to offset greater volatility of credit ratios?EXHIBIT 10A Mallinckrodt PLC Financial Statements Year End 30 Sept.* 2015 2,923.1 Consolidated Statements of

Income before income taxes and non-controlling interest Provision (Benefit) for income taxes Net income

EXHIBIT 10B Mallinckrodt PLC Financial Statements Year End 30 Sept.* 2015 Consolidated Balance Sheets

LIABILITIES AND EQUITY Current liabilities: Current maturities of long-term debt Accounts payable Accrued

EXHIBIT 10B (Continued) Consolidated Balance Sheets (Dollars in millions) Shareholders' equity: Ordinary

EXHIBIT 10C Mallinckrodt PLC Financial Statements Year End 30 Sept.* 2015 Consolidated Statements of Cash

Cash Flows from Investing Activities: Capital expenditures Acquisitions and intangibles, net of cash acquired

Consolidated Statements of Cash Flow (Dollars in millions) Cash Flows from Financing Activities: Issuance of

EXHIBIT 10D Mallinckrodt PLC Credit Ratios 2015 12.1% 6.3x 4.0x 12.0% 55.0% Operating margin Debt/EBITDA

EXHIBIT 11 Johnson & Johnson's Credit Ratios 2015 26.2% 0.9x 40.1x 81.1% 22.0% Operating profit margin

EXHIBIT 12 ArcelorMittal Credit Ratios Operating profit margin Debt/EBITDA EBITDA/Interest FCF after

Fantastic news! We've Found the answer you've been seeking!

Step by Step Answer:

Related Book For  answer-question

Fixed Income Analysis

ISBN: 9781119850540

5th Edition

Authors: Barbara S. Petitt

Question Posted: